Uwell Biopharma, Inc. (TPEX:7902)
46.95
+1.00 (2.18%)
At close: Apr 27, 2026
| Market Cap | 9.39B |
| Revenue (ttm) | 450.00K |
| Net Income (ttm) | -54.86M |
| Shares Out | 200.00M |
| EPS (ttm) | -0.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 420,766 |
| Average Volume | 390,473 |
| Open | 46.00 |
| Previous Close | 45.95 |
| Day's Range | 44.65 - 48.35 |
| 52-Week Range | 7.80 - 51.50 |
| Beta | n/a |
| RSI | 62.53 |
| Earnings Date | n/a |